COLUMBIA, Md.--(BUSINESS WIRE)--Celsion Corporation (NASDAQ: CLSN), a biotechnology drug development company that is leveraging its heat sensitive liposomal technology platform to encapsulate and deliver high concentrations of proven chemotherapeutics, today announced that it would hold a conference call to discuss first quarter 2009 results at 11:00 a.m. Eastern Time on Tuesday, May 12, 2009. To participate in the call, interested parties may dial (877) 604-2080 (U.S./Canada) or (706) 902–1383 (International) and use Conference ID: #98823295 to register ten minutes before the call is scheduled to begin. The call will also be broadcast live on the internet at http://www.celsion.com.
